Morgan Stanley’s GeneDx Holdings WGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45M | Buy |
487,070
+274,604
| +129% | +$25.3M | ﹤0.01% | 2024 |
|
|
2025
Q1 | $18.8M | Sell |
212,466
-366
| -0.2% | -$32.4K | ﹤0.01% | 2758 |
|
|
2024
Q4 | $16.4M | Buy |
212,832
+14,479
| +7% | +$1.11M | ﹤0.01% | 2955 |
|
|
2024
Q3 | $8.42M | Sell |
198,353
-39,188
| -16% | -$1.66M | ﹤0.01% | 3556 |
|
|
2024
Q2 | $6.21M | Sell |
237,541
-555,940
| -70% | -$14.5M | ﹤0.01% | 3712 |
|
|
2024
Q1 | $7.24M | Sell |
793,481
-774,775
| -49% | -$7.07M | ﹤0.01% | 3597 |
|
|
2023
Q4 | $4.31M | Buy |
1,568,256
+1,564,589
| +42,667% | +$4.3M | ﹤0.01% | 4459 |
|
|
2023
Q3 | $13.3K | Sell |
3,667
-6,211
| -63% | -$22.6K | ﹤0.01% | 6620 |
|
|
2023
Q2 | $58.9K | Buy |
9,878
+2,646
| +37% | +$15.8K | ﹤0.01% | 6150 |
|
|
2023
Q1 | $87.1K | Buy |
7,232
+469
| +7% | +$5.65K | ﹤0.01% | 6068 |
|
|
2022
Q4 | $58.9K | Buy |
6,763
+4,205
| +164% | +$36.6K | ﹤0.01% | 6220 |
|
|
2022
Q3 | $74K | Sell |
2,558
-7,361
| -74% | -$213K | ﹤0.01% | 6228 |
|
|
2022
Q2 | $413K | Buy |
9,919
+5,257
| +113% | +$219K | ﹤0.01% | 5514 |
|
|
2022
Q1 | $472K | Sell |
4,662
-117,392
| -96% | -$11.9M | ﹤0.01% | 5436 |
|
|
2021
Q4 | $18M | Buy |
122,054
+11,509
| +10% | +$1.69M | ﹤0.01% | 2274 |
|
|
2021
Q3 | $27.7M | Buy |
110,545
+109,650
| +12,251% | +$27.5M | ﹤0.01% | 1757 |
|
|
2021
Q2 | $414K | Sell |
895
-1,754
| -66% | -$811K | ﹤0.01% | 5640 |
|
|
2021
Q1 | $1.3M | Buy |
2,649
+1,482
| +127% | +$728K | ﹤0.01% | 4562 |
|
|
2020
Q4 | $425K | Buy |
+1,167
| New | +$425K | ﹤0.01% | 5179 |
|